Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-04-25, Stock:JNJ, The news for the past five days is as follows:
2018-04-18: NEWS1: 3 Dividend ETFs With High Inflows in April.NEWS2: 3 Dividend ETFs With High Inflows in April.NEWS3: After the Bell: Dow Drops 38 Points Because…IBM.NEWS4: Kentucky Gov. Matt Bevin slams state AG&apos;s lawsuit against J&J: &apos;These are political moves&apos;.NEWS5: Kentucky Gov. Matt Bevin slams state AG's lawsuit against J&J: 'These are political moves'.NEWS6: Kentucky Governor Bevin: I'm not on board with JNJ opioid....NEWS7: Expect Stocks to Continue Forward Momentum.NEWS8: Expect Stocks to Continue Forward Momentum.NEWS9: Dow Movers: IBM, HD.NEWS10: Dow Movers: IBM, HD.NEWS11: QUAL, JNJ, MMM, SCHW: Large Inflows Detected at ETF.NEWS12: QUAL, JNJ, MMM, SCHW: Large Inflows Detected at ETF.NEWS13: Kentucky accuses J&J of contributing to opioid epidemic.NEWS14: IBM and J&J stocks cut 100 points from Dow industrials in early trading.NEWS15: Kentucky accuses J&J of contributing to opioid epidemic.NEWS16: IBM and J&J stocks cut nearly 100 points from Dow industrials in early trade.NEWS17: MARKETS: The real test for stocks is coming from the bond market.NEWS18: Zoetis Inc. (ZTS) Ex-Dividend Date Scheduled for April 19, 2018.NEWS19: Zoetis Inc. (ZTS) Ex-Dividend Date Scheduled for April 19, 2018.NEWS20: Location revealed: Johnson & Johnson institute&apos;s new HQ to go in Lake Nona&apos;s Medical City.NEWS21: The resume of the future will tell employers who you are, and not just what you’ve done.NEWS22: [$$] Johnson & Johnson Raises Sales Outlook.NEWS23: Asian Shares Rise As China Cuts Banks' Reserve Requirements.NEWS24: Asian Shares Rise As China Cuts Banks' Reserve Requirements.NEWS25: European Shares Seen Higher At Open.NEWS26: European Shares Seen Higher At Open.
2018-04-19: NEWS1: P&G, GE and IBM Need to Innovate; Has Starbucks' Stock Grown Ice Cold?--ICYMI.NEWS2: Healthcare ETFs in Focus After Johnson & Johnson Q1 Earnings.NEWS3: Healthcare ETFs in Focus After Johnson & Johnson Q1 Earnings.NEWS4: Healthcare ETFs in Focus After Johnson & Johnson Q1 Earnings.NEWS5: 3 Drugs That Are Moving the Needle at Johnson & Johnson.NEWS6: 3 Drugs That Are Moving the Needle at Johnson & Johnson.NEWS7: 3 Drugs That Are Moving the Needle at Johnson & Johnson.
2018-04-20: NEWS1: 4 Blue-Chip Stocks to Buy Ahead of Eye-Popping Earnings.NEWS2: J&J, Novartis' Q1 Earnings Impress: Will Others Follow Suit?.NEWS3: J&J, Novartis' Q1 Earnings Impress: Will Others Follow Suit?.NEWS4: Pharma Stock Roundup: NVS, JNJ Q1 Sales & Earnings Top, MRK & BMY Active at AACR.NEWS5: Dow 30 Stock Roundup: AmEx, Goldman, IBM, JNJ, P&G, UNH Earnings Impress.NEWS6: Dow 30 Stock Roundup: AmEx, Goldman, IBM, JNJ, P&G, UNH Earnings Impress.NEWS7: J&J, Novartis&apos; Q1 Earnings Impress: Will Others Follow Suit?.NEWS8: AbbVie And Other Great Pharma And Biotech Income Stocks.NEWS9: Dow 30 Stock Roundup: AmEx, Goldman, IBM, JNJ, P&G, UNH Earnings Impress.NEWS10: Johnson & Johnson is betting on vision care and expanding beyond contacts.NEWS11: Johnson & Johnson is betting on vision care and expanding beyond contacts.
2018-04-23: NEWS1: Johnson & Johnson’s Revenues Continued to Rise in 1Q18.NEWS2: Drug/Biotech Stock Q1 Earnings Due on Apr 24: LLY, BIIB, AMGN.NEWS3: Drug/Biotech Stock Q1 Earnings Due on Apr 24: LLY, BIIB, AMGN.NEWS4: Johnson & Johnson's Top-Line Growth Isn't What It Seems.NEWS5: Johnson & Johnson's Top-Line Growth Isn't What It Seems.NEWS6: Analysts’ Estimates for Eli Lilly & Co.’s 1Q18 Earnings.NEWS7: Johnson & Johnson&apos;s Top-Line Growth Isn&apos;t What It Seems.NEWS8: Geron Corporation: The Clock Is Ticking.NEWS9: Geron Corporation: The Clock Is Ticking.NEWS10: Geron Corporation: The Clock Is Ticking.NEWS11: Why GlaxoSmithKline’s 1Q18 Revenues Are Expected to Fall.NEWS12: Merck’s Relebactam Met Primary Endpoints in Phase 3 Study.NEWS13: British businesses embrace profits with a purpose.
2018-04-24: NEWS1: Top Research Reports for Johnson & Johnson, Honeywell & Morgan Stanley.NEWS2: Top Research Reports for Johnson & Johnson, Honeywell & Morgan Stanley.NEWS3: Top Research Reports for Johnson & Johnson, Honeywell & Morgan Stanley.NEWS4: Johnson & Johnson to Participate in the 2018 Deutsche Bank 43rd Annual Health Care Conference.NEWS5: Biktarvy Could Be a Major Driver for Gilead Sciences in 2018.NEWS6: NEWS BITES: Police look for motive in deadly Toronto van attack, President George H.W. Bush hospitalized, Prince's family suing hospital that treated him.NEWS7: How Johnson & Johnson’s Pharmaceutical Segment Performed in 1Q18.NEWS8: Analyzing Johnson & Johnson’s Segment-Wise Performance in 1Q18.

Answer: Rise